Placental DNA methylation levels at CYP2E1 and IRS2 are associated with child outcome in a prospective autism study.
Placental DNA methylation levels at CYP2E1 and IRS2 are associated with child outcome in a prospective autism study.
复制标题
在一项前瞻性自闭症研究中,胎盘 DNA CYP2E1 和 IRS2 甲基化水平与儿童结局相关。
DOI:
10.1093/hmg/ddz084
复制
发表时间:
2019
影响因子:
3.5
通讯作者:
LaSalle,JanineM
中科院分区:
文献类型:
--
作者:
Zhu,Yihui;Mordaunt,CharlesE;Yasui,DagH;Marathe,Ria;Coulson,RochelleL;Dunaway,KeithW;Jianu,JuliaM;Walker,CherylK;Ozonoff,Sally;Hertz-Picciotto,Irva;Schmidt,RebeccaJ;LaSalle,JanineM
DNA methylation acts at the interface of genetic and environmental factors relevant for autism spectrum disorder (ASD). Placenta, normally discarded at birth, is a potentially rich source of DNA methylation patterns predictive of ASD in the child. Here, we performed whole methylome analyses of placentas from a prospective study MARBLES (Markers of Autism Risk in Babies—Learning Early Signs) of high-risk pregnancies. A total of 400 differentially methylated regions (DMRs) discriminated placentas stored from children later diagnosed with ASD compared to typically developing controls. These ASD DMRs were significantly enriched at promoters, mapped to 596 genes functionally enriched in neuronal development, and overlapped genetic ASD risk. ASD DMRs atCYP2E1andIRS2reached genome-wide significance, replicated by pyrosequencing and correlated with expression differences in brain. Methylation atCYP2E1associated with both ASD diagnosis and genotype within the DMR. In contrast, methylation atIRS2was unaffected by within DMR genotype but modified by preconceptional maternal prenatal vitamin use. This study therefore identified two potentially useful early epigenetic markers for ASD in placenta.